🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06649071
Enrolling by invitation Observational

Clinical Classification and Imaging Markers in Patients of Obesity

NCT06649071 · tracked via the Priya Life Science China tracker
Sponsor
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase
Observational
Started
2024-10-20
Last updated
2024-10-18

Condition(s) studied

ObesityfMRIClinical Classification

Investigational drug(s) / intervention(s)

Naturalistic observation

Naturalistic observation: Naturalistic observation

Study summary

This is an observational study to explore the etiology and clinical classification in patients with obesity and to achieve personalized treatment.

Eligibility

Sex
ALL
Min age
20 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Patients with BMI≥28kg/m2 * Aged 18-65 years of both sexes, right-handed * At least 6 years of education * Patients agreed and signed the informed consent Exclusion Criteria: * Fewer than 6 years of education * Left-handedness * Dementia * Acute metabolic complications such as diabetic ketoacidosis * Hyperglycaemic hyperosmolar state and hypoglycaemic coma within the previous 3 months; history or presence of neurological or psychiatric disorders; * Presence of hypothyroidism; * History of malignancy, or severe kidney or liver dysfunction.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Department of Endocrinology, Endocrine and Metabolic Disease Medical Center, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University Nanjing Jiangsu

More The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06649071 on ClinicalTrials.gov ↗ ← All trials in China